(Q24242906)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

glycogen storage disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Robert J. Beynon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andrea Martinuzzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Rosaline Quinlivan

1

0 references

Robert J Beynon

2

0 references

Andrea Martinuzzi

3

0 references

publication date

16 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

CD003458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

Oral branched-chain amino acids do not improve exercise capacity in McArdle disease.

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

The effect of oral sucrose on exercise tolerance in patients with McArdle's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Psychophysical bases of perceived exertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Phenotype modulators in myophosphorylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

A metabolic myopathy due to absence of muscle phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Genotype modulators of clinical severity in McArdle disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Treatment of glycogenosis type V with ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

McArdle's disease: Molecular genetics and metabolic consequences of the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

Are high-protein diets effective in McArdle's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

A comparative study on glucagon effect between mcardle disease and tarui disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

McArdle's disease: successful symptomatic therapy by high dose oral administration of ribose

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Low muscle levels of pyridoxine in McArdle's syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Dantrolene sodium does influence the second-wind phenomenon in McArdle's disease. Electrophysiological evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

144th ENMC International Workshop: Outcome Measures in McArdle Disease, 29 September-1 November 2006, Naarden, The Netherlands

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Beneficial effects of dantrolene sodium in exercise-induced muscle pains: calcium mediated?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Myopathy in McArdle's syndrome. Improvement with a high-protein diet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

McArdle's syndrome: the reaction to a fat-rich diet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Improved energy kinetics following high protein diet in McArdle's syndrome. A 31P magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Long-term creatine intake is beneficial to muscle performance during resistance training.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Exercise to exhaustion in the second-wind phase of exercise in a case of McArdle's disease with and without creatine supplementation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

Why do patients with McArdle's disease have decreased exercise capacity?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003458.PUB3

7 January 2021

10.1002/14651858.CD003458.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference